Isolation and characterization of microparticles in sputum from cystic fibrosis patients

Respiratory Research

Volumn 11, Issue , 2010, Pages

  Porro, Chiara ^a   Lepore, Silvia ^a   Trotta, Teresa ^a   Castellani, Stefano ^a   Ratclif, Luigi ^b   Battaglino, Anna ^b   Di Gioia, Sante ^a   Martínez, Maria C ^c   Conese, Massimo ^a   Maffione, Angela B ^a  

^a UNIVERSITY OF FOGGIA   (Italy)

^b Ospedale G Tatarella   (Italy)

^c UNIVERSITÉ D'ANGERS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD66B ANTIGEN; LYMPHOCYTE ANTIGEN; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; UNCLASSIFIED DRUG; CEACAM8 PROTEIN, HUMAN; CELL ADHESION MOLECULE; ITGAM PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADULT; AIRWAY OBSTRUCTION; ANTIBODY LABELING; ARTICLE; CILIARY DYSKINESIA; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOFLUOROMETRY; ELECTRON MICROSCOPY; FEMALE; HUMAN; MALE; MEMBRANE MICROPARTICLE; NONHUMAN; PHENOTYPE; PRIMARY CILIARY DYSKINESIA; PSEUDOMONAS AERUGINOSA; SPUTUM; STAPHYLOCOCCUS AUREUS; TRANSMISSION ELECTRON MICROSCOPY; ACUTE DISEASE; COMPARATIVE STUDY; CYTOLOGY; FLOW CYTOMETRY; GRANULOCYTE; IMMUNOLOGY; IMMUNOPHENOTYPING; KARTAGENER SYNDROME; LEUKOCYTE; MACROPHAGE; PARTICLE SIZE; PATHOLOGY; ULTRASTRUCTURE;

ACUTE DISEASE; ADULT; ANTIGENS, CD; ANTIGENS, CD11A; ANTIGENS, CD11B; CELL ADHESION MOLECULES; CELL-DERIVED MICROPARTICLES; CYSTIC FIBROSIS; FEMALE; FLOW CYTOMETRY; GRANULOCYTES; HUMANS; IMMUNOPHENOTYPING; KARTAGENER SYNDROME; LEUKOCYTES; MACROPHAGES; MALE; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; PHENOTYPE; SPUTUM; YOUNG ADULT;

EID: 77956705683     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-11-94     Document Type: Article

References (47)

1. Bonfield TL, Panuska JR, Konstan MW, Hilliard KA, Hilliard JB, Ghnaim H, Berger M. Inflammatory cytokines in cystic fibrosis lungs. Am J Respir Crit Care Med 1995, 152:2111-2118.
2. Muhlebach MS, Reed W, Noah TL. Quantitative cytokine gene expression in CF airway. Pediatr Pulmonol 2004, 37(5):393-399. 10.1002/ppul.20010, 15095321.
3. Khan TZ, Wagener JS, Bost T, Martinez J, Accurso FJ, Riches DWH. Early pulmonary inflammation in infants with cystic fibrosis. Am J Respir Crit Care Med 1995, 151:1075-1082.
4. Corvol H, Fitting C, Chadelat K, Jacquot J, Tabary O, Boule M, Cavaillon JM, Clement A. Distinct cytokine production by lung and blood neutrophils from children with cystic fibrosis. Am J Physiol Lung Cell Mol Physiol 2003, 284(6):L997-1003.
5. Makam M, Diaz D, Laval J, Gernez Y, Conrad CK, Dunn CE, Davies ZA, Moss RB, Herzenberg LA, Herzenberg LA, et al. Activation of critical, host-induced, metabolic and stress pathways marks neutrophil entry into cystic fibrosis lungs. Proc Natl Acad Sci USA 2009, 106(14):5779-5783. 10.1073/pnas.0813410106, 2667067, 19293384.
6. Tirouvanziam R, Gernez Y, Conrad CK, Moss RB, Schrijver I, Dunn CE, Davies ZA, Herzenberg LA, Herzenberg LA. Profound functional and signaling changes in viable inflammatory neutrophils homing to cystic fibrosis airways. Proc Natl Acad Sci USA 2008, 105(11):4335-4339. 10.1073/pnas.0712386105, 2393742, 18334635.
7. Petit-Bertron AF, Tabary O, Corvol H, Jacquot J, Clement A, Cavaillon JM, Adib-Conquy M. Circulating and airway neutrophils in cystic fibrosis display different TLR expression and responsiveness to interleukin-10. Cytokine 2008, 41(1):54-60. 10.1016/j.cyto.2007.10.012, 18054497.
8. Conese M, Copreni E, Di Gioia S, De Rinaldis P, Fumarulo R. Neutrophil recruitment and airway epithelial cell involvement in chronic cystic fibrosis lung disease. J Cystic Fibrosis 2003, 2:129-135.
9. Downey DG, Bell SC, Elborn JS. Neutrophils in cystic fibrosis. Thorax 2009, 64(1):81-88. 10.1136/thx.2007.082388, 19103874.
10. Watt AP, Courtney J, Moore J, Ennis M, Elborn JS. Neutrophil cell death, activation and bacterial infection in cystic fibrosis. Thorax 2005, 60(8):659-664. 10.1136/thx.2004.038240, 1747479, 16061707.
11. Vandivier RW, Fadok VA, Hoffmann PR, Bratton DL, Penvari C, Brown KK, Brain JD, Accurso FJ, Henson PM. Elastase-mediated phosphatidylserine receptor cleavage impairs apoptotic cell clearance in cystic fibrosis and bronchiectasis. J Clin Invest 2002, 109(5):661-670. 150889, 11877474.
12. Vandivier RW, Richens TR, Horstmann SA, deCathelineau AM, Ghosh M, Reynolds SD, Xiao YQ, Riches DW, Plumb J, Vachon E, et al. Dysfunctional cystic fibrosis transmembrane conductance regulator inhibits phagocytosis of apoptotic cells with proinflammatory consequences. Am J Physiol Lung Cell Mol Physiol 2009, 297(4):L677-686. 10.1152/ajplung.00030.2009, 2770781, 19633071.
13. Tabary O, Corvol H, Boncoeur E, Chadelat K, Fitting C, Cavaillon JM, Clement A, Jacquot J. Adherence of airway neutrophils and inflammatory response are increased in CF airway epithelial cell-neutrophil interactions. Am J Physiol Lung Cell Mol Physiol 2006, 290(3):L588-596. 10.1152/ajplung.00013.2005, 16272177.
14. Hartl D, Latzin P, Hordijk P, Marcos V, Rudolph C, Woischnik M, Krauss-Etschmann S, Koller B, Reinhardt D, Roscher AA, et al. Cleavage of CXCR1 on neutrophils disables bacterial killing in cystic fibrosis lung disease. Nat Med 2007, 13(12):1423-1430. 10.1038/nm1690, 18059279.
15. Sagel SD, Chmiel JF, Konstan MW. Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc 2007, 4(4):406-417. 10.1513/pats.200703-044BR, 2647605, 17652508.
16. Nicholas B, Djukanovic R. Induced sputum: a window to lung pathology. Biochem Soc Trans 2009, 37(Pt 4):868-872. 10.1042/BST0370868, 19614609.
17. Nomura S, Ozaki Y, Ikeda Y. Function and role of microparticles in various clinical settings. Thromb Res 2008, 123(1):8-23. 10.1016/j.thromres.2008.06.006, 18667228.
18. Benameur T, Andriantsitohaina R, Martinez MC. Therapeutic potential of plasma membrane-derived microparticles. Pharmacol Rep 2009, 61(1):49-57.
19. Mostefai HA, Meziani F, Mastronardi ML, Agouni A, Heymes C, Sargentini C, Asfar P, Martinez MC, Andriantsitohaina R. Circulating microparticles from patients with septic shock exert protective role in vascular function. Am J Respir Crit Care Med 2008, 178(11):1148-1155. 10.1164/rccm.200712-1835OC, 18723433.
20. Meziani F, Tesse A, David E, Martinez MC, Wangesteen R, Schneider F, Andriantsitohaina R. Shed membrane particles from preeclamptic women generate vascular wall inflammation and blunt vascular contractility. Am J Pathol 2006, 169(4):1473-1483. 10.2353/ajpath.2006.051304, 1780189, 17003500.
21. Agouni A, Lagrue-Lak-Hal AH, Ducluzeau PH, Mostefai HA, Draunet-Busson C, Leftheriotis G, Heymes C, Martinez MC, Andriantsitohaina R. Endothelial dysfunction caused by circulating microparticles from patients with metabolic syndrome. Am J Pathol 2008, 173(4):1210-1219. 10.2353/ajpath.2008.080228, 2543087, 18772329.
22. Tual-Chalot S, Guibert C, Muller B, Savineau JP, Andriantsitohaina R, Martinez MC. Circulating Microparticles from Pulmonary Hypertensive Rats Induce Endothelial Dysfunction. Am J Respir Crit Care Med 2010,
23. Couper KN, Barnes T, Hafalla JC, Combes V, Ryffel B, Secher T, Grau GE, Riley EM, de Souza JB. Parasite-derived plasma microparticles contribute significantly to malaria infection-induced inflammation through potent macrophage stimulation. PLoS Pathog 2010, 6(1):e1000744. 10.1371/journal.ppat.1000744, 2813278, 20126448.
24. Martinez MC, Tesse A, Zobairi F, Andriantsitohaina R. Shed membrane microparticles from circulating and vascular cells in regulating vascular function. Am J Physiol Heart Circ Physiol 2005, 288(3):H1004-1009. 10.1152/ajpheart.00842.2004, 15706036.
25. Mutschler DK, Larsson AO, Basu S, Nordgren A, Eriksson MB. Effects of mechanical ventilation on platelet microparticles in bronchoalveolar lavage fluid. Thromb Res 2002, 108(4):215-220. 10.1016/S0049-3848(03)00005-7, 12617984.
26. Bastarache JA, Fremont RD, Kropski JA, Bossert FR, Ware LB. Procoagulant alveolar microparticles in the lungs of patients with acute respiratory distress syndrome. Am J Physiol Lung Cell Mol Physiol 2009, 297(6):L1035-1041. 10.1152/ajplung.00214.2009, 2793184, 19700643.
27. Wolter JM, Rodwell RL, Bowler SD, McCormack JG. Cytokines and inflammatory mediators do not indicate acute infection in cystic fibrosis. Clin Diagn LabImmunol 1999, 6:260-265.
28. Levy H, Kalish LA, Huntington I, Weller N, Gerard C, Silverman EK, Celedon JC, Pier GB, Weiss ST. Inflammatory markers of lung disease in adult patients with cystic fibrosis. Pediatr Pulmonol 2007, 42(3):256-262. 10.1002/ppul.20563, 17245735.
29. Saiman L, Siegel J. Infection control recommendations for patients with cystic fibrosis: Microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission. Am J Infect Control 2003, 31(3 Suppl):S1-62.
30. Stover CK, Pham XQ, Erwin AL, Mizoguchi SD, Warrener P, Hickey MJ, Brinkman FS, Hufnagle WO, Kowalik DJ, Lagrou M, et al. Complete genome sequence of Pseudomonas aeruginosa PAO1, an opportunistic pathogen. Nature 2000, 406:959-964. 10.1038/35023079, 10984043.
31. Sagel SD. Noninvasive biomarkers of airway inflammation in cystic fibrosis. Curr Opin Pulm Med 2003, 9(6):516-521. 10.1097/00063198-200311000-00012, 14534405.
32. Mayer-Hamblett N, Aitken ML, Accurso FJ, Kronmal RA, Konstan MW, Burns JL, Sagel SD, Ramsey BW. Association between pulmonary function and sputum biomarkers in cystic fibrosis. Am J Respir Crit Care Med 2007, 175(8):822-828. 10.1164/rccm.200609-1354OC, 2720115, 17234902.
33. Janowska-Wieczorek A, Majka M, Kijowski J, Baj-Krzyworzeka M, Reca R, Turner AR, Ratajczak J, Emerson SG, Kowalska MA, Ratajczak MZ. Platelet-derived microparticles bind to hematopoietic stem/progenitor cells and enhance their engraftment. Blood 2001, 98(10):3143-3149. 10.1182/blood.V98.10.3143, 11698303.
34. Hubeau C, Lorenzato M, Couetil JP, Hubert D, Dusser D, Puchelle E, Gaillard D. Quantitative analysis of inflammatory cells infiltrating the cystic fibrosis airway mucosa. Clin Exp Immunol 2001, 124(1):69-76. 10.1046/j.1365-2249.2001.01456.x, 1906034, 11359444.
35. Livraghi A, Randell SH. Cystic fibrosis and other respiratory diseases of impaired mucus clearance. Toxicol Pathol 2007, 35(1):116-129. 10.1080/01926230601060025, 17325980.
36. Zihlif N, Paraskakis E, Tripoli C, Lex C, Bush A. Markers of airway inflammation in primary ciliary dyskinesia studied using exhaled breath condensate. Pediatr Pulmonol 2006, 41(6):509-514. 10.1002/ppul.20344, 16617444.
37. Noone PG, Leigh MW, Sannuti A, Minnix SL, Carson JL, Hazucha M, Zariwala MA, Knowles MR. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 2004, 169(4):459-467. 10.1164/rccm.200303-365OC, 14656747.
38. Cohen Z, Gonzales RF, Davis-Gorman GF, Copeland JG, McDonagh PF. Thrombin activity and platelet microparticle formation are increased in type 2 diabetic platelets: a potential correlation with caspase activation. Thromb Res 2002, 107(5):217-221. 10.1016/S0049-3848(02)00334-1, 12479881.
39. Mostefai HA, Andriantsitohaina R, Martinez MC. Plasma membrane microparticles in angiogenesis: role in ischemic diseases and in cancer. Physiol Res 2008, 57(3):311-320.
40. Cocucci E, Racchetti G, Meldolesi J. Shedding microvesicles: artefacts no more. Trends Cell Biol 2009, 19(2):43-51. 10.1016/j.tcb.2008.11.003, 19144520.
41. Shet AS. Characterizing blood microparticles: technical aspects and challenges. Vasc Health Risk Manag 2008, 4(4):769-774. 2597765, 19065994.
42. Ratajczak J, Wysoczynski M, Hayek F, Janowska-Wieczorek A, Ratajczak MZ. Membrane-derived microvesicles: important and underappreciated mediators of cell-to-cell communication. Leukemia 2006, 20(9):1487-1495. 10.1038/sj.leu.2404296, 16791265.
43. Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999, 94(11):3791-3799.
44. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008, 3(11):e3694. 10.1371/journal.pone.0003694, 2577891, 19002258.
45. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D. Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 2010, 10(2):111-122. 10.1038/nri2708, 20098459.
46. Tsitsiou E, Lindsay MA. microRNAs and the immune response. Curr Opin Pharmacol 2009, 9(4):514-520. 10.1016/j.coph.2009.05.003, 2742742, 19525145.
47. Gray RD, MacGregor G, Noble D, Imrie M, Dewar M, Boyd AC, Innes JA, Porteous DJ, Greening AP. Sputum proteomics in inflammatory and suppurative respiratory diseases. Am J Respir Crit Care Med 2008, 178(5):444-452. 10.1164/rccm.200703-409OC, 2643212, 18565957.